Centre EPIC
Montreal, Quebec, H1T 1N6, Canada
Location contact
Jonathan Tremblay, PhD
PRINCIPAL_INVESTIGATOR
Louis Behrer, PhD
CONTACT
Philippe Parent, BSc
SUB_INVESTIGATOR
Simon-Olivier Cloutier, MSc
CONTACT
+1-514-374-1480 ext. 4259
NCT Number: NCT07389837
The goal of this clinical trial is to learn whether maple syrup can be used as a natural carbohydrate source to help trained male cyclists perform better during long-duration cycling. The study also aims to learn how different amounts of maple syrup affect energy use in the body, stomach comfort, and feelings of effort and fatigue.
The main questions the study aims to answer are:
* Does consuming more carbohydrate from maple syrup help participants finish a 20-kilometer cycling time trial faster? * How do different amounts of maple syrup change how the body uses carbohydrates and fats during long exercise? * Are higher amounts of maple syrup easy for participants to tolerate without stomach problems?
Researchers will compare four drinks:
1. A placebo drink (a look-alike drink with no calories), 2. A drink that provides 60 grams of carbohydrate per hour, 3. A drink that provides 90 grams per hour, and 4. A drink that provides 120 grams per hour.
They will compare these drinks to see whether higher carbohydrate amounts lead to better cycling performance and how each dose affects comfort and metabolism.
Participants will:
* Attend a screening visit that includes a health check and a glucose tolerance test. * Complete a fitness test to measure their aerobic capacity and practice the cycling tests used in the study. * Take part in four separate exercise sessions in random order. Each session includes: * Drinking one of the four study beverages during 2 hours of steady cycling, * Completing two short, all-out 6-second sprints during the ride, * Completing a 20-kilometer cycling time trial as fast as possible, * Reporting stomach symptoms and perceptions of effort, * Providing breath, blood, urine, and sweat samples so researchers can measure how their body uses fuel.
All drinks will look, taste, and smell similar so participants cannot tell which one they are receiving. Meals before each session will be provided to keep conditions the same across visits.
This study may help athletes and active people choose natural carbohydrate sources that support both performance and comfort during long endurance exercise. The findings may also guide future research on the use of maple syrup as a sports nutrition option.
Trial opening soon.
Get Notified18 year–45 year
Male
Interventional
Not applicable
Montreal, Quebec, H1T 1N6, Canada
Jonathan Tremblay, PhD
PRINCIPAL_INVESTIGATOR
Louis Behrer, PhD
CONTACT
Philippe Parent, BSc
SUB_INVESTIGATOR
Simon-Olivier Cloutier, MSc
CONTACT
+1-514-374-1480 ext. 4259
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pure maple syrup is diluted in water and mixed with electrolytes (sodium, potassium, magnesium) to resemble a sports drink. Participants receive one of three carbohydrate doses (60, 90, or 120 g per hour). Drinks are ingested every 15 minutes during 120 minutes of cycling, for a total of ~750 mL per hour. All doses have the same volume, temperature, electrolyte content, and schedule.
Participants receive a calorie-free electrolyte drink designed to mimic maple syrup. Sotolon (maple aroma) and stevia are added in small amounts to reproduce sweetness, flavor, and smell without providing energy. The drink is administered in identical volumes and timing to the maple syrup beverages (~750 mL per hour, every 15 minutes).
To control nutrition before each trial, participants are provided with a standardized dinner the night before and a standardized breakfast 2-3 hours before testing. Meals contain the same calories and macronutrient distribution across all sessions. Participants must also replicate their training during the previous 48 hours.
At 30 minutes of cycling, participants ingest a small, safe dose of deuterium oxide (7-8 mL) to measure fluid absorption and gastric emptying. Additional blood samples are collected at +32, +35, and +40 minutes to capture early absorption. Urine is collected to measure deuterium enrichment and validate absorption kinetics.
After 120 minutes of steady cycling, participants complete a 20-km self-paced time trial. Only distance is displayed. The primary outcome is completion time; mean power is analyzed as supportive information.
Energy metabolism is measured using indirect calorimetry and ¹³C-sucrose breath enrichment. Samples are collected at rest and every 30 minutes during exercise to quantify carbohydrate and fat use, distinguishing ingested vs. stored carbohydrate oxidation. Urine and sweat correct protein oxidation.
Blood samples collected every 30 minutes measure glucose, insulin, lactate, and fatty acids. Samples are stored for later analysis of hormonal and metabolic responses.
Participants rate stomach symptoms (0-10 scale) before exercise, every 30 minutes during cycling, and after the time trial. Scores quantify total, upper, and lower GI discomfort.
Effort and muscle pain are assessed using the Borg CR100 scale during exercise and throughout the time trial at preset intervals.
Participants perform two 6-second maximal sprints at baseline, 60 and 120 minutes of cycling, and after the time trial. Peak power, cadence, and torque assess fatigue progression and recovery.
Immediately post-exercise, a 0-100 mm scale evaluates sweetness, flavor intensity, and overall liking to assess palatability of each drink.
Bang's Blinding Index is calculated from participant guesses of drink identity to confirm whether blinding was successful.
Time frame: Immediately after completion of the 20-km time trial during each experimental visit
20-km time trial completion time (minutes), measured at the end of each experimental visit.
Time frame: At rest, immediately before exercise, and every 30 minutes during 120 minutes of constant-load cycling
Exogenous and endogenous carbohydrate oxidation, fat oxidation, and protein oxidation rates (g·min-¹) measured via ¹³C stable isotope breath enrichment and indirect calorimetry.
Time frame: Measured before beverage ingestion, immediately pre-exercise, every 30 minutes during the 120-minute constant-load cycling, and immediately post-exercise (before the time trial).
Plasma glucose, insulin, lactate, and free fatty acid concentrations sampled before beverage ingestion, pre-exercise, every 30 minutes during constant-load exercise, and immediately after.
Time frame: Assessed 3 minutes after exercise begins; every 30 minutes during the constant-load cycling (30, 60, 90, 120 min); and at approximately 126, 127, 130, 136, and 145 minutes (corresponding to 0.5, 5, 10, 15, and 20 km during the time trial)
Ratings of perceived effort (CR100 scale, 0-100) collected after 3 minutes and every 30 minutes during constant-load exercise, and during the time trial.
Time frame: Measured pre-exercise; every 30 minutes during the 120-minute constant-load cycling (30, 60, 90, 120 min); and immediately after the time trial.
Gastrointestinal distress scores (0-10 on a modified visual analog scale, mVAS), rated pre-exercise, every 30 minutes during the constant-load exercise, and post-TT; includes composite scores for total, upper, and lower GI symptoms.
Time frame: Baseline, 60 minutes, 120 minutes, and immediately after time trial
Peak power output (watts) from two 6-second maximal sprints performed at baseline, 60 minutes, 120 minutes, and post-time trial.
Time frame: Approximately 25-30 minutes (continuously recorded during the 20-km time trial)
Mean power output (watts) recorded continuously during the 20-km time trial.
Time frame: Immediately after time trial completion
Hedonic ratings for sweetness, flavor intensity, and overall liking (0-100 mm visual analog scale) assessed immediately post-exercise.
Time frame: Evaluated using oxidation values measured during cycling (at rest, pre-exercise, and at 30, 60, 90, 120 min) and TT performance measured at approximately 150-155 minutes (immediately after time trial completion)
Correlation coefficients (e.g., Pearson's r) between exogenous/endogenous oxidation rates and TT time to completion or mean power output.
Time frame: Calculated from repeated TT measurements collected at each of 4 experimental visits over approximately 4-6 weeks
Within-subject and inter-individual coefficients of variation for TT time to completion and mean power output across doses.
Time frame: Measured via plasma samples at baseline, 30 min (pre-ingestion), and at +32, +35, +40 min, then every 30 min during cycling (60, 90, 120 min), plus within 30 minutes after time trial completion (approximately 150-180 min)
Deuterium oxide (D2O) tracer kinetics, including absorption rate constant, time-to-peak plasma enrichment (tmax), and area under the curve (AUC), derived from plasma and urine D/H enrichment samples.
Time frame: Moderation assessed using TT outcomes collected at each of 4 experimental visits over approximately 4-8 weeks, combined with participant baseline characteristics collected at screening visit
Moderation analysis using interaction terms in linear mixed-effects models (e.g., carbohydrate dose × body weight) for TT time to completion.
Time frame: Baseline (before beverage ingestion), immediately before exercise, at 60 minutes of constant-load cycling, pre-TT (~125 minutes after beginning constand-load cycling), and post-TT (~150-160 minutes).
Untargeted metabolomic profiling via high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS) on plasma samples collected at before beverage ingestion, before the start of exercise, at 60 minutes into constant-load exercise, pre- and post-TT; focuses on pathways such as glycolysis, lipid oxidation, and amino acid metabolism.
Contact information is provided by the study sponsor or research team.
Université de Montréal
Other
Dose-Response Effects of Maple Syrup Carbohydrate Ingestion (60, 90, 120 g/h) on 20-km Cycling Time-Trial Performance, Substrate Oxidation, and Perceptual Responses in Trained Male Cyclists
Acronym: MAPLE-DR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736027
Adhesive Capsulitis, Adhesive Capsulitis of the Shoulder
Istanbul, Kadikoy, Turkey (Türkiye)
View Trial DetailsNCT06880315
Behavior, Exercise
View Trial DetailsNCT07671638
Behavior, Exercise
La Tronche, France
View Trial DetailsNCT07711340
Behavior, Exercise
Stanford, California, United States
View Trial Details